المؤلفون: Curigliano, G, Dent, R, Llombart-Cussac, A, Pegram, M, Pusztai, L, Turner, N, Viale, G

المساهمون: Turner, Nicholas

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Oncology, ENDOCRINE THERAPY, 70-GENE SIGNATURE, TREATMENT DECISIONS, PROGNOSTIC VALUE, OPEN-LABEL, EXPRESSION, STAGE, INDEX, PALBOCICLIB, LETROZOLE

جغرافية الموضوع: United States

وصف الملف: Electronic; application/pdf

العلاقة: ARTN 56; npj Breast Cancer, 2023, 9 (1), pp. 56 -; https://repository.icr.ac.uk/handle/internal/5983Test

الإتاحة: https://doi.org/10.1038/s41523-023-00560-zTest
https://repository.icr.ac.uk/handle/internal/5983Test

المؤلفون: Curigliano G., Mueller V., Borges V., Hamilton E., Hurvitz S., Loi S., Murthy R., Okines A., Paplomata E., Cameron D., Carey L. A., Gelmon K., Hortobagyi G. N., Krop I., Loibl S., Pegram M., Slamon D., Ramos J., Feng W., Winer E.

المساهمون: G. Curigliano, V. Mueller, V. Borge, E. Hamilton, S. Hurvitz, S. Loi, R. Murthy, A. Okine, E. Paplomata, D. Cameron, L.A. Carey, K. Gelmon, G.N. Hortobagyi, I. Krop, S. Loibl, M. Pegram, D. Slamon, J. Ramo, W. Feng, E. Winer

مصطلحات موضوعية: brain metastase, capecitabine, human epidermal growth factor receptor 2-positive (HER2), metastatic breast cancer, trastuzumab, tucatinib, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34954044; info:eu-repo/semantics/altIdentifier/wos/WOS:000755659500011; volume:33; issue:3; firstpage:321; lastpage:329; numberofpages:9; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/2434/910202Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123294615

الإتاحة: https://doi.org/10.1016/j.annonc.2021.12.005Test
http://hdl.handle.net/2434/910202Test

المؤلفون: Curigliano, G, Mueller, V, Borges, V, Hamilton, E, Hurvitz, S, Loi, S, Murthy, R, Okines, A, Paplomata, E, Cameron, D, Carey, LA, Gelmon, K, Hortobagyi, GN, Krop, I, Loibl, S, Pegram, M, Slamon, D, Ramos, J, Feng, W, Winer, E

العلاقة: pii: S0923-7534(21)04879-1; Curigliano, G., Mueller, V., Borges, V., Hamilton, E., Hurvitz, S., Loi, S., Murthy, R., Okines, A., Paplomata, E., Cameron, D., Carey, L. A., Gelmon, K., Hortobagyi, G. N., Krop, I., Loibl, S., Pegram, M., Slamon, D., Ramos, J., Feng, W. & Winer, E. (2022). Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis. Ann Oncol, 33 (3), pp.321-329. https://doi.org/10.1016/j.annonc.2021.12.005Test.; http://hdl.handle.net/11343/308715Test

الإتاحة: https://doi.org/10.1016/j.annonc.2021.12.005Test
http://hdl.handle.net/11343/308715Test

المؤلفون: Rugo H. S., Im S. -A., Cardoso F., Cortes J., Curigliano G., Musolino A., Pegram M. D., Wright G. S., Saura C., Escriva-De-Romani S., De Laurentiis M., Levy C., Brown-Glaberman U., Ferrero J. -M., De Boer M., Kim S. -B., Petrakova K., Yardley D. A., Freedman O., Jakobsen E. H., Kaufman B., Yerushalmi R., Fasching P. A., Nordstrom J. L., Bonvini E., Koenig S., Edlich S., Hong S., Rock E. P., Gradishar W. J.

المساهمون: H.S. Rugo, S.-. Im, F. Cardoso, J. Corte, G. Curigliano, A. Musolino, M.D. Pegram, G.S. Wright, C. Saura, S. Escriva-De-Romani, M. De Laurentii, C. Levy, U. Brown-Glaberman, J.-. Ferrero, M. De Boer, S.-. Kim, K. Petrakova, D.A. Yardley, O. Freedman, E.H. Jakobsen, B. Kaufman, R. Yerushalmi, P.A. Fasching, J.L. Nordstrom, E. Bonvini, S. Koenig, S. Edlich, S. Hong, E.P. Rock, W.J. Gradishar

مصطلحات موضوعية: Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33480963; info:eu-repo/semantics/altIdentifier/wos/WOS:000609546400001; volume:7; issue:4; firstpage:573; lastpage:584; numberofpages:12; journal:JAMA ONCOLOGY; http://hdl.handle.net/2434/825172Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85099823030

الإتاحة: https://doi.org/10.1001/jamaoncol.2020.7932Test
http://hdl.handle.net/2434/825172Test

المؤلفون: van de Stolpe, A., Verhaegh, W., Blay, J.Y., Ma, C.X., Pauwels, P., Pegram, M., Prenen, H., De Ruysscher, D., Saba, N.F., Slovin, S.F., Willard-Gallo, K., Husain, H.

المصدر: van de Stolpe , A , Verhaegh , W , Blay , J Y , Ma , C X , Pauwels , P , Pegram , M , Prenen , H , De Ruysscher , D , Saba , N F , Slovin , S F , Willard-Gallo , K & Husain , H 2021 , ' RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies ' , Frontiers in Genetics , vol. 11 , 598118 . https://doi.org/10.3389/fgene.2020.598118Test

مصطلحات موضوعية: low input analytes, mrna profiling, oncology precision medicine, signaling pathway activity, treatment prediction

الإتاحة: https://doi.org/10.3389/fgene.2020.598118Test
https://cris.maastrichtuniversity.nl/en/publications/cc345075-5dcd-418c-b549-71bf8718457aTest

المؤلفون: Sharma, M.R., Carvajal, R.D., Hanna, G.J., Kang, Y.K., Lee, J., Lee, K.W., Li, B.T., Moore, K.N., Pegram, M., Rasco, D., Spira, A., Wang, D., Weinberg, B.A., Alonso, M., Fang, L., Husain, A., Kowanetz, M., Perez, E.A., Dumbrava, E.I.

المصدر: Annals of Oncology ; volume 32, page S1453-S1454 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2021.10.183Test
https://api.elsevier.com/content/article/PII:S0923753421047190?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753421047190?httpAccept=text/plainTest

المؤلفون: Rugo H. S., Im S. -A., Cardoso F., Cortes J., Curigliano G., Musolino A., Pegram M. D., Bachelot T., Wright G. S., Saura C., Escriva-De-Romani S., De Laurentiis M., Schwartz G. N., Pluard T. J., Ricci F., Gwin W. R., Levy C., Brown-Glaberman U., Ferrero J. -M., De Boer M., Kim S. -B., Petrakova K., Yardley D. A., Freedman O., Jakobsen E. H., Gal-Yam E. N., Yerushalmi R., Fasching P. A., Kaufman P. A., Ashley E. J., Perez-Olle R., Hong S., Rosales M. K., Gradishar W. J.

المساهمون: Rugo, H. S., Im, S. -A., Cardoso, F., Cortes, J., Curigliano, G., Musolino, A., Pegram, M. D., Bachelot, T., Wright, G. S., Saura, C., Escriva-De-Romani, S., De Laurentiis, M., Schwartz, G. N., Pluard, T. J., Ricci, F., Gwin, W. R., Levy, C., Brown-Glaberman, U., Ferrero, J. -M., De Boer, M., Kim, S. -B., Petrakova, K., Yardley, D. A., Freedman, O., Jakobsen, E. H., Gal-Yam, E. N., Yerushalmi, R., Fasching, P. A., Kaufman, P. A., Ashley, E. J., Perez-Olle, R., Hong, S., Rosales, M. K., Gradishar, W. J.

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000921267800009; volume:41; issue:2; firstpage:198; lastpage:205; numberofpages:8; journal:JOURNAL OF CLINICAL ONCOLOGY; https://hdl.handle.net/11588/922320Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85145668861

الإتاحة: https://doi.org/10.1200/JCO.21.02937Test
https://hdl.handle.net/11588/922320Test

المؤلفون: Stebbing J., Mainwaring P. N., Curigliano G., Pegram M., Latymer M., Bair A. H., Rugo H. S.

المساهمون: J. Stebbing, P.N. Mainwaring, G. Curigliano, M. Pegram, M. Latymer, A.H. Bair, H.S. Rugo

مصطلحات موضوعية: Biosimilar Pharmaceutical, Breast Neoplasm, Clinical Trials as Topic, Human, Neoplasm, Randomized Controlled Trials as Topic, Therapeutic Equivalency, Trastuzumab, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32058846; info:eu-repo/semantics/altIdentifier/wos/WOS:000526810500008; volume:38; issue:10; firstpage:1070; lastpage:1080; numberofpages:11; journal:JOURNAL OF CLINICAL ONCOLOGY; http://hdl.handle.net/2434/824552Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85082560767

الإتاحة: https://doi.org/10.1200/JCO.19.02953Test
http://hdl.handle.net/2434/824552Test

المؤلفون: Murthy, R. K., Loi, S., Okines, A., Paplomata, E., Hamilton, E., Hurvitz, S. A., Lin, N. U., Borges, V., Abramson, V., Anders, C., Bedard, P. L., Oliveira, M., Jakobsen, E., Bachelot, T., Shachar, S. S., Muller, V., Braga, S., Duhoux, F. P., Greil, R., Cameron, D., Carey, L. A., Curigliano, G., Gelmon, K., Hortobagyi, G., Krop, I., Loibl, S., Pegram, M., Slamon, D., Palanca-Wessels, M. C., Walker, L., Feng, W., Winer, E. P.

المصدر: Murthy , R K , Loi , S , Okines , A , Paplomata , E , Hamilton , E , Hurvitz , S A , Lin , N U , Borges , V , Abramson , V , Anders , C , Bedard , P L , Oliveira , M , Jakobsen , E , Bachelot , T , Shachar , S S , Muller , V , Braga , S , Duhoux , F P , Greil , R , Cameron , D , Carey , L A , Curigliano , G , Gelmon , K , ....

مصطلحات موضوعية: Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Brain Neoplasms/secondary, Breast Neoplasms/drug therapy, Capecitabine/administration & dosage, Consolidation Chemotherapy, Diarrhea/chemically induced, Double-Blind Method, Female, Humans, Kaplan-Meier Estimate, Middle Aged, Progression-Free Survival, Protein-Tyrosine Kinases/antagonists & inhibitors, Receptor, ErbB-2/analysis, Trastuzumab/administration & dosage

وصف الملف: application/pdf

العلاقة: https://portal.findresearcher.sdu.dk/da/publications/68464b3b-6eae-4ed1-9926-219625af6304Test

الإتاحة: https://doi.org/10.1056/NEJMoa1914609Test
https://portal.findresearcher.sdu.dk/da/publications/68464b3b-6eae-4ed1-9926-219625af6304Test
https://findresearcher.sdu.dk/ws/files/170528833/NEJMoa1914609.pdfTest

المؤلفون: Kittaneh, M., Badve, S., Caldera, H., Coleman, R., Goetz, M.P., Mahtani, R., Mamounas, E., Kalinsky, K., Lower, E., Pegram, M., Press, M.F., Rugo, H.S., Schwartzberg, L., Traina, T., Vogel, C.

وصف الملف: text

العلاقة: https://eprints.whiterose.ac.uk/159607/8/1-s2.0-S1526820920300045-main.pdfTest; Kittaneh, M., Badve, S., Caldera, H. et al. (12 more authors) (2020) Case-based review and olinical guidance on the use of genomic assays for early-stage breast cancer: Breast Cancer Therapy Expert Group (BCTEG). Clinical Breast Cancer, 20 (3). pp. 183-193. ISSN 1526-8209

الإتاحة: https://eprints.whiterose.ac.uk/159607Test/
https://eprints.whiterose.ac.uk/159607/8/1-s2.0-S1526820920300045-main.pdfTest